Prognostic implication of the CpG island methylator phenotype in colorectal cancers depends on tumour location

British Journal of Cancer

Volumn 109, Issue 4, 2013, Pages 1004-1012

  Bae, J M ^a   Kim, J H ^a   Cho, N Y ^a   Kim, T Y ^a   Kang, G H ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

MUCIN;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CECUM; CLINICAL FEATURE; COLORECTAL CANCER; CPG ISLAND; DISEASE FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; RECTUM; SEX DIFFERENCE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; CPG ISLANDS; DNA METHYLATION; DNA, NEOPLASM; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; PHENOTYPE; PROGNOSIS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS B-RAF; RAS PROTEINS; RECTAL NEOPLASMS; SEX FACTORS; YOUNG ADULT;

EID: 84883142215     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.430     Document Type: Article

References (61)

1. Arai T, Kino I (1989) Morphometrical and cell kinetic studies of normal human colorectal mucosa. Comparison between the proximal and the distal large intestine. Acta Pathol Jpn 39(11): 725-730.
2. Barault L, Charon-Barra C, Jooste V, de la Vega MF, Martin L, Roignot P, Rat P, Bouvier AM, Laurent-Puig P, Faivre J, Chapusot C, Piard F (2008) Hypermethylator phenotype in sporadic colon cancer: study on a population-based series of 582 cases. Cancer Res 68(20): 8541-8546.
3. Benedix F, Kube R, Meyer F, Schmidt U, Gastinger I, Lippert H (2010) Comparison of 17641 patients with right-And left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival. Dis Colon Rectum 53(1): 57-64.
4. Benedix F, Meyer F, Kube R, Kropf S, Kuester D, Lippert H, Roessner A, Kruger S (2012) Influence of anatomical subsite on the incidence of microsatellite instability, and KRAS and BRAF mutation rates in patients with colon carcinoma. Pathol Res Pract 208(10): 592-597.
5. Benedix F, Schmidt U, Mroczkowski P, Gastinger I, Lippert H, Kube R (2011) Colon carcinoma-classification into right and left sided cancer or according to colonic subsite?-Analysis of 29568 patients. Eur J Surg Oncol 37(2): 134-139.
6. Boland CR, Goel A (2010) Microsatellite instability in colorectal cancer. Gastroenterology 138(6): 2073-2087, e3.
7. Breivik J, Lothe RA, Meling GI, Rognum TO, Borresen-Dale AL, Gaudernack G (1997) Different genetic pathways to proximal and distal colorectal cancer influenced by sex-related factors. Int J Cancer 74(6): 664-669.
8. Bufill JA (1990) Colorectal cancer: evidence for distinct genetic categories based on ximal or distal tumor location. Ann Int Med 113(10): 779-788.
9. Caldero J, Campo E, Ascaso C, Ramos J, Panades MJ, Rene JM (1989) Regional distribution of glycoconjugates in normal, transitional and neoplastic human colonic mucosa. A histochemical study using lectins. Virch Arch A Pathol Anat Histopathol 415(4): 347-356.
10. Chang SC, Lin JK, Yang SH, Wang HS, Li AF, Chi CW (2006) Relationship between genetic alterations and prognosis in sporadic colorectal cancer. Int J Cancer 118(7): 1721-1727.
11. Cheung DY, Kim TH, Kim CW, Kim JI, Cho SH, Park SH, Han JY, Kim JK (2008) The anatomical distribution of colorectal cancer in Korea: evaluation of the incidence of proximal and distal lesions and synchronous adenomas. Int Med 47(19): 1649-1654.
12. Dahlin AM, Palmqvist R, Henriksson ML, Jacobsson M, Eklof V, Rutegard J, Oberg A, Van Guelpen BR (2010) The role of the CpG island methylator phenotype in colorectal cancer prognosis depends on microsatellite instability screening status. Clin Cancer Res 16(6): 1845-1855.
13. Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61(5): 759-767.
14. Fleming RE, Parkkila S, Parkkila AK, Rajaniemi H, Waheed A, Sly WS (1995) Carbonic anhydrase IV expression in rat and human gastrointestinal tract regional, cellular, and subcellular localization. J Clin Invest 96(6): 2907-2913.
15. Gao J, Sun ZW, Li YY, Shen L (2012) [Mutations of KRAS and BRAF in Chinese patients with colorectal carcinoma: analyses of 966 cases]. Chinese J Pathol 41(9): 579-583.
16. Glebov OK, Rodriguez LM, Nakahara K, Jenkins J, Cliatt J, Humbyrd CJ, DeNobile J, Soballe P, Simon R, Wright G, Lynch P, Patterson S, Lynch H, Gallinger S, Buchbinder A, Gordon G, Hawk E, Kirsch IR (2003) Distinguishing right from left colon by the pattern of gene expression. Cancer Epidemiol Biomark Prev 12(8): 755-762.
17. Hinoue T, Weisenberger DJ, Lange CP, Shen H, Byun HM, Van Den Berg D, Malik S, Pan F, Noushmehr H, van Dijk CM, Tollenaar RA, Laird PW (2012) Genome-scale analysis of aberrant DNA methylation in colorectal cancer. Genome Res 22(2): 271-282.
18. Hjartaker A, Aagnes B, Robsahm TE, Langseth H, Bray F, Larsen IK (2013) Subsite-specific dietary risk factors for colorectal cancer: a review of cohort studies. J Oncol 2013: 703854.
19. Hughes LA, Williamson EJ, van Engeland M, Jenkins MA, Giles GG, Hopper JL, Southey MC, Young JP, Buchanan DD, Walsh MD, van den Brandt PA, Alexandra Goldbohm R, Weijenberg MP, English DR (2012) Body size and risk for colorectal cancers showing BRAF mutations or microsatellite instability: a pooled analysis. Int J Epidemiol 41(4): 1060-1072.
20. Iacopetta B (2002) Are there two sides to colorectal cancer? Int J Cancer 101(5): 403-408.
21. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. Cancer J Clin 61(2): 69-90.
22. Jensen OM (1984) Different age and sex relationship for cancer of subsites of the large bowel. Br J Cancer 50(6): 825-829.
23. Jung KW, Won YJ, Kong HJ, Oh CM, Seo HG, Lee JS (2013) Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010. Cancer Res Treatment 45(1): 1-14.
24. Kang GH (2011) Four molecular subtypes of colorectal cancer and their precursor lesions. Arch Pathol Lab Med 135(6): 698-703.
25. Kim JH, Shin SH, Kwon HJ, Cho NY, Kang GH (2009) Prognostic implications of CpG island hypermethylator phenotype in colorectal cancers. Virchows Arch 455(6): 485-494.
26. Komuro K, Tada M, Tamoto E, Kawakami A, Matsunaga A, Teramoto K, Shindoh G, Takada M, Murakawa K, Kanai M, Kobayashi N, Fujiwara Y, Nishimura N, Hamada J, Ishizu A, Ikeda H, Kondo S, Katoh H, Moriuchi T, Yoshiki T (2005) Right-And left-sided colorectal cancers display distinct expression profiles and the anatomical stratification allows a high accuracy prediction of lymph node metastasis. J Surg Res 124(2): 216-224.
27. Lee S, Cho NY, Choi M, Yoo EJ, Kim JH, Kang GH (2008) Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation. Pathol Int 58(2): 104-113.
28. Li FY, Lai MD (2009) Colorectal cancer, one entity or three. J Zhejiang Univ Sci B 10(3): 219-229.
29. Limburg PJ, Limsui D, Vierkant RA, Tillmans LS, Wang AH, Lynch CF, Anderson KE, French AJ, Haile RW, Harnack LJ, Potter JD, Slager SL, Smyrk TC, Thibodeau SN, Cerhan Jr. (2012) Postmenopausal hormone therapy and colorectal cancer risk in relation to somatic KRAS mutation status among older women. Cancer Epidemiol Biomark Prev 21(4): 681-684.
30. Limsui D, Vierkant RA, Tillmans LS, Wang AH, Weisenberger DJ, Laird PW, Lynch CF, Anderson KE, French AJ, Haile RW, Harnack LJ, Potter JD, Slager SL, Smyrk TC, Thibodeau SN, Cerhan JR, Limburg PJ (2010) Cigarette smoking and colorectal cancer risk by molecularly defined subtypes. J Natl Cancer Inst 102(14): 1012-1022.
31. Lin CC, Lai YL, Lin TC, Chen WS, Jiang JK, Yang SH, Wang HS, Lan YT, Liang WY, Hsu HM, Lin JK, Chang SC (2012) Clinicopathologic features and prognostic analysis of MSI-high colon cancer. Int J Colorectal Dis 27(3): 277-286.
32. Macfarlane GT, Gibson GR, Cummings JH (1992) Comparison of fermentation reactions in different regions of the human colon. J Appl Bacteriol 72(1): 57-64.
33. Majumdar SR, Fletcher RH, Evans AT (1999) How does colorectal cancer present? Symptoms, duration, and clues to location. Am J Gastroenterol 94(10): 3039-3045.
34. Mercurio MG, Shiff SJ, Galbraith RA, Sassa S (1995) Expression of cytochrome P450 mRNAs in the colon and the rectum in normal human subjects. Biochem Biophys Res Commun 210(2): 350-355.
35. Nosho K, Irahara N, Shima K, Kure S, Kirkner GJ, Schernhammer ES, Hazra A, Hunter DJ, Quackenbush J, Spiegelman D, Giovannucci EL, Fuchs CS, Ogino S (2008) Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample. PloS One 3(11): e3698.
36. Ogino S, Chan AT, Fuchs CS, Giovannucci E (2011) Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Gut 60(3): 397-411.
37. Ogino S, Lochhead P, Chan AT,Nishihara R, Cho E,Wolpin BM, Meyerhardt JA, Meissner A, Schernhammer ES, Fuchs CS, Giovannucci E (2013) Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease. Mod Pathol 26(4): 465-484.
38. Ogino S, Nosho K, Kirkner GJ, Kawasaki T, Meyerhardt JA, Loda M, Giovannucci EL, Fuchs CS (2009) CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer. Gut 58(1): 90-96.
39. Ogino S, Odze RD, Kawasaki T, Brahmandam M, Kirkner GJ, Laird PW, Loda M, Fuchs CS (2006) Correlation of pathologic features with CpG island methylator phenotype (CIMP) by quantitative DNA methylation analysis in colorectal carcinoma. Am J Surg Pathol 30(9): 1175-1183.
40. Popat S, Hubner R, Houlston RS (2005) Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol 23(3): 609-618.
41. Rhee YY, Kim MJ, Bae JM, Koh JM, Cho NY, Juhnn YS, Kim D, Kang GH (2012) Clinical outcomes of patients with microsatellite-unstable colorectal carcinomas depend on L1 methylation level. Ann Surg Oncol 19(11): 3441-3448.
42. Robsahm TE, Aagnes B, Hjartaker A, Langseth H, Bray FI, Larsen IK (2013) Body mass index, physical activity, and colorectal cancer by anatomical subsites: a systematic review and meta-Analysis of cohort studies. Eur J Cancer Prev; e-pub ahead of print 14 April 2013.
43. Rosty C, Young JP, Walsh MD, Clendenning M, Walters RJ, Pearson S, Pavluk E, Nagler B, Pakenas D, Jass JR, Jenkins MA, Win AK, Southey MC, Parry S, Hopper JL, Giles GG, Williamson E, English DR, Buchanan DD (2013) Colorectal carcinomas with KRAS mutation are associated with distinctive morphological and molecular features. Mod Pathol 26: 825-834.
44. Roth AD, Delorenzi M, Tejpar S, Yan P, Klingbiel D, Fiocca R, d'Ario G, Cisar L, Labianca R, Cunningham D, Nordlinger B, Bosman F, Van Cutsem E (2012) Integrated analysis of molecular and clinical prognostic factors in stage II/III colon cancer. J Natl Cancer Inst 104(21): 1635-1646.
45. Russo A, Bazan V, Iacopetta B, Kerr D, Soussi T, Gebbia N (2005) The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment. J Clin Oncol 23(30): 7518-7528.
46. Saltzstein SL, Behling CA (2007) Age and time as factors in the left-to-right shift of the subsite of colorectal adenocarcinoma: a study of 213,383 cases from the California Cancer Registry. J Clin Gastroenterol 41(2): 173-177.
47. Sanchez JA, Krumroy L, Plummer S, Aung P, Merkulova A, Skacel M, DeJulius KL, Manilich E, Church JM, Casey G, Kalady MF (2009) Genetic and epigenetic classifications define clinical phenotypes and determine patient outcomes in colorectal cancer. Br J Surg 96(10): 1196-1204.
48. Shen L, Catalano PJ, Benson 3rd AB, O'Dwyer P, Hamilton SR, Issa JP (2007) Association between DNA methylation and shortened survival in patients with advanced colorectal cancer treated with 5-fluorouracil based chemotherapy. Clin Cancer Res 13(20): 6093-6098.
49. Skinner SA, O'Brien PE (1996) The microvascular structure of the normal colon in rats and humans. J Surg Res 61(2): 482-490.
50. Slattery ML, Curtin K, Wolff RK, Boucher KM, Sweeney C, Edwards S, Caan BJ, Samowitz W (2009) A comparison of colon and rectal somatic DNA alterations. Dis Colon Rectum 52(7): 1304-1311.
51. Smith G, Carey FA, Beattie J, Wilkie MJ, Lightfoot TJ, Coxhead J, Garner RC, Steele RJ, Wolf CR (2002) Mutations in APC, Kirsten-ras, and p53-Alternative genetic pathways to colorectal cancer. Proc Natl Acad Sci USA 99(14): 9433-9438.
52. Sugai T, Habano W, Jiao YF, Tsukahara M, Takeda Y, Otsuka K, Nakamura S (2006) Analysis of molecular alterations in left-And right-sided colorectal carcinomas reveals distinct pathways of carcinogenesis: proposal for new molecular profile of colorectal carcinomas. J Mol Diagn 8(2): 193-201.
53. Sung JJ, Lau JY, Goh KL, Leung WK (2005) Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol 6(11): 871-876.
54. Takada H, Ohsawa T, Iwamoto S, Yoshida R, Nakano M, Imada S, Yoshioka K, Okuno M, Masuya Y, Hasegawa K, Kamano N, Hioki K, Muto T, Koyama Y (2002) Changing site distribution of colorectal cancer in Japan. Dis Colon Rectum 45(9): 1249-1254.
55. The Cancer Genome Atlas Network (2012) Comprehensive molecular characterization of human colon and rectal cancer. Nature 487(7407): 330-337.
56. Thomas LA, Veysey MJ, French G, Hylemon PB, Murphy GM, Dowling RH (2001) Bile acid metabolism by fresh human colonic contents: a comparison of caecal versus faecal samples. Gut 49(6): 835-842.
57. Weisenberger DJ, Siegmund KD, Campan M, Young J, Long TI, Faasse MA, Kang GH, Widschwendter M, Weener D, Buchanan D, Koh H, Simms L, Barker M, Leggett B, Levine J, Kim M, French AJ, Thibodeau SN, Jass J, Haile R, Laird PW (2006) CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 38(7): 787-793.
58. Wolf BC, Salem RR, Sears HF, Horst DA, Lavin PT, Herlyn M, Itzkowitz SH, Schlom J, Steele Jr. GD (1989) The expression of colorectal carcinomaassociated antigens in the normal colonic mucosa. An immunohistochemical analysis of regional distribution. Am J Pathol 135(1): 111-119.
59. Yamauchi M, Lochhead P, Morikawa T, Huttenhower C, Chan AT, Giovannucci E, Fuchs C, Ogino S (2012a) Colorectal cancer: a tale of two sides or a continuum? Gut 61(6): 794-797.
60. Yamauchi M, Morikawa T, Kuchiba A, Imamura Y, Qian ZR, Nishihara R, Liao X, Waldron L, Hoshida Y, Huttenhower C, Chan AT, Giovannucci E, Fuchs C, Ogino S (2012b) Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum. Gut 61(6): 847-854.
61. Zehnter E, Roisch U, Kruis W, Breuer C, Diehl V (1996) Ornithine decarboxylase levels in patients with normal colonic mucosa. Eur J Clin Chem Clin Biochem 34(7): 529-533.